Published in Clin Exp Immunol on March 01, 1989
Extracellular organelles (prostasomes) are immunosuppressive components of human semen. Clin Exp Immunol (1991) 1.02
Reciprocal interactions between human T-lymphotropic virus type 1 and prostaglandins: implications for viral transmission. J Virol (2001) 0.97
Eicosanomic profiling reveals dominance of the epoxygenase pathway in human amniotic fluid at term in spontaneous labor. FASEB J (2014) 0.89
Autoimmune T cell responses to seminal plasma in chronic pelvic pain syndrome (CPPS). Clin Exp Immunol (2002) 0.85
Evaluation of the significance of polyamines and their oxidases in the aetiology of human cervical carcinoma. Br J Cancer (1995) 0.84
T-cell receptor/CD28 engagement when combined with prostaglandin E2 treatment leads to potent activation of human T-cell leukemia virus type 1. J Virol (2003) 0.84
Transactivator protein BICP0 of bovine herpesvirus 1 (BHV-1) is blocked by prostaglandin D2 (PGD2), which points to a mechanism for PGD2-mediated inhibition of BHV-1 replication. J Virol (2004) 0.75
Regulation of human B cell proliferation and differentiation by seminal plasma. Clin Exp Immunol (1991) 0.75
G proteins and dual control of adenylate cyclase. Cell (1984) 11.05
Regulation of the immune response by prostaglandins. J Clin Immunol (1983) 3.12
Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression. J Immunol (1985) 1.86
Lymphokine regulation of activated (G1) lymphocytes. I. Prostaglandin E2-induced inhibition of interleukin 2 production. J Immunol (1983) 1.66
An IgG-Fc binding protein in seminal fluid. Am J Reprod Immunol (1983) 1.48
Regulation of interleukin 2 synthesis by cAMP in human T cells. J Immunol (1987) 1.47
Measurement by radioimmunoassay of prostaglandins as their methyl oximes. Prostaglandins Leukot Med (1986) 1.43
Immunosuppressive activity of human seminal plasma. I. Inhibition of in vitro lymphocyte activation. J Immunol (1977) 1.26
Immunology of semen. Fertil Steril (1987) 1.11
Suppression of epididymal sperm antigenicity in the rabbit by uteroglobin and transglutaminase in vitro. Science (1983) 1.08
Suppressive effect of seminal plasma on lymphocyte activation. Nature (1975) 1.06
Inhibition of in vitro immune responses by a fraction from seminal plasma. Scand J Immunol (1976) 1.03
Prostaglandin concentrations in the semen of fertile men. J Reprod Fertil (1978) 1.00
Regulation of some functions of granulocytes by zinc of the prostatic fluid and prostate tissue. J Lab Clin Med (1976) 1.00
Inhibition of lymphocyte transformation by pregnancy-associated plasma protein-A (PAPP-A). J Clin Lab Immunol (1982) 1.00
Immunosuppressive effects of mouse seminal plasma components in vivo and in vitro. J Immunol (1982) 0.99
Suppression of natural killer cell activity by human seminal plasma in vitro: identification of 19-OH-PGE as the suppressor factor. J Immunol (1986) 0.94
Prostaglandin E2 inhibits human T-cell proliferation after crosslinking of the CD3-Ti complex by directly affecting T cells at an early step of the activation process. Cell Immunol (1987) 0.93
19-Hydroxyprostaglandin E1 as a major component of the semen of primates. Nature (1976) 0.92
Rectal insemination modifies immune responses in rabbits. Science (1984) 0.91
The relation between fertility and prostaglandin content of seminal fluid in man. Fertil Steril (1970) 0.84
Human seminal plasma is a potent inhibitor of natural killer cell activity in vitro. J Reprod Immunol (1985) 0.84
Prostaglandin E2, a seminal constituent, facilitates the replication of acquired immune deficiency syndrome virus in vitro. Proc Natl Acad Sci U S A (1986) 0.84
The identification of factors in seminal plasma responsible for suppression of natural killer cell activity. Immunology (1988) 0.84
Studies on the immunosuppressive effect of seminal plasma. Br J Urol (1987) 0.83
The role of prostaglandins in the regulation of cell proliferation. Prostaglandins Leukot Essent Fatty Acids (1988) 0.82
The influence of prostaglandins on sperm motility. Prostaglandins (1981) 0.81
The genome sequence of Schizosaccharomyces pombe. Nature (2002) 14.26
The genome of the social amoeba Dictyostelium discoideum. Nature (2005) 9.18
BioJava: an open-source framework for bioinformatics. Bioinformatics (2008) 6.17
Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results. J Natl Cancer Inst (2000) 5.62
Anti-lymphocytic antibody--a review. Clin Exp Immunol (1967) 2.75
Alfuzosin once daily facilitates return to voiding in patients in acute urinary retention. J Urol (2004) 2.49
BCG immunotherapy of bladder cancer: 20 years on. Lancet (1999) 2.38
Human monoclonal antibody production. Current status and future prospects. J Immunol Methods (1987) 2.21
Is a male infertility clinic of any use? Br J Urol (1986) 2.16
Laboratory staff qualifications and accuracy of proficiency test results. A national study. Arch Pathol Lab Med (1992) 2.07
The effect of pH on release of PGE2 from vaginal and endocervical preparations for induction of labour: an in-vitro study. Br J Obstet Gynaecol (1992) 2.02
The natural history of Peyronie's disease. J Urol (1990) 2.02
Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a double-blind placebo-controlled study. Urology (2005) 2.01
Effect of antilymphocytic antibody and antibody fragments on human lymphocytes in vitro. Nature (1967) 1.89
EAU guidelines on male infertility. Eur Urol (2005) 1.82
Psychotic men remanded in custody to Brixton Prison. Br J Psychiatry (1994) 1.77
Circadian variation of lymphocyte subpopulations: a study with monoclonal antibodies. Br Med J (Clin Res Ed) (1983) 1.72
Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer. Int J Gynecol Cancer (2003) 1.70
Radio-immunoassay detection of interferon-gamma in urine after intravesical Evans BCG therapy. J Urol (1990) 1.66
The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up. J Urol (1996) 1.63
Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: an Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group. J Clin Oncol (1999) 1.63
A genomewide suppressor and enhancer analysis of cdc13-1 reveals varied cellular processes influencing telomere capping in Saccharomyces cerevisiae. Genetics (2008) 1.58
Some factors influencing the ability of anti-lymphocytic antibody to suppress humoral antibody formation. Clin Exp Immunol (1967) 1.52
Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma. J Clin Oncol (2002) 1.50
The preparation and properties of anti-lymphocytic sera. Prog Surg (1969) 1.48
On the nature and extent of XY pairing at meiotic prophase in man. Cytogenet Cell Genet (1984) 1.46
[Surgical treatment of the single non traumatic perforation of small bowel: excision-suture or resection-anastomosis]. Ann Chir (2005) 1.45
Melatonin administration can entrain the free-running circadian system of blind subjects. J Endocrinol (2000) 1.43
Measurement by radioimmunoassay of prostaglandins as their methyl oximes. Prostaglandins Leukot Med (1986) 1.43
Structure-property correlations in a combinatorial library of degradable biomaterials. J Biomed Mater Res (1998) 1.42
Continuous thoracic epidural analgesia versus combined spinal/thoracic epidural analgesia on pain, pulmonary function and the metabolic response following colonic resection. Acta Anaesthesiol Scand (1996) 1.42
Effect of antilymphocytic antibody and antibody fragments on skin-homograft survival and the blood-lymphocyte count in rats. Lancet (1967) 1.41
Effect of anti-rat lymphocyte antibody on humoral antibody formation. Nature (1967) 1.40
Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party). Br Med J (Clin Res Ed) (1988) 1.39
Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall. J Urol (1992) 1.38
Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding. Br J Obstet Gynaecol (1981) 1.34
Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (1996) 1.32
Comparison of prednisolone and placebo in subfertile men with antibodies to spermatozoa. Lancet (1990) 1.31
Mutations at the mitochondrial DNA polymerase (POLG) locus associated with male infertility. Nat Genet (2001) 1.31
Characterisation of the coding sequence and fine mapping of the human DFFRY gene and comparative expression analysis and mapping to the Sxrb interval of the mouse Y chromosome of the Dffry gene. Hum Mol Genet (1998) 1.30
Expression of RBM in the nuclei of human germ cells is dependent on a critical region of the Y chromosome long arm. Proc Natl Acad Sci U S A (1997) 1.29
Characterization of antilymphocytic antibody. Nature (1967) 1.27
Quality-adjusted time without symptoms or toxicity analysis of interferon maintenance in multiple myeloma. J Clin Oncol (1998) 1.27
Characterization of symptomatic and asymptomatic carotid plaques using high-resolution real-time ultrasonography. Br J Surg (1993) 1.26
The distribution and possible significance of cells identified in human lymphoid tissue by the monoclonal antibody HNK-1. Clin Exp Immunol (1983) 1.25
Multiple organ damage caused by a new toxin azaspiracid, isolated from mussels produced in Ireland. Toxicon (2000) 1.23
New allele at cholinesterase locus 1. J Med Genet (1976) 1.20
Microdeletions in interval 6 of the Y chromosome of males with idiopathic sterility point to disruption of AZF, a human spermatogenesis gene. Hum Genet (1992) 1.19
Towards the molecular localisation of the AZF locus: mapping of microdeletions in azoospermic men within 14 subintervals of interval 6 of the human Y chromosome. Hum Mol Genet (1992) 1.19
Fibroblast heterogeneity: existence of functionally distinct Thy 1(+) and Thy 1(-) human female reproductive tract fibroblasts. Am J Pathol (2001) 1.18
Normal and pathological serum levels of alpha2-macroglobulins in men and mice. J Clin Pathol (1975) 1.18
Role of inflammatory mediators in human endometrium during progesterone withdrawal and early pregnancy. J Clin Endocrinol Metab (1999) 1.17
Prolongation of canine renal allograft survival with antilymphocytic serum. Transplantation (1968) 1.16
Cytokine secretion by human fetal membranes, decidua and placenta at term. Hum Reprod (1998) 1.16
The effect of anti-lymphocytic antibody on the humoral immune response in different strains of mice. I. The response to bovine serum albumin. Immunology (1972) 1.15
Changes in urinary cytokines and soluble intercellular adhesion molecule-1 (ICAM-1) in bladder cancer patients after bacillus Calmette-Guérin (BCG) immunotherapy. Clin Exp Immunol (1995) 1.14
Sperm abnormalities and cigarette smoking. Lancet (1981) 1.14
Sustained-release alfuzosin and trial without catheter after acute urinary retention: a prospective, placebo-controlled. BJU Int (1999) 1.14
Flexible eating and flexible insulin dosing in patients with diabetes: Results of an intensive self-management course. Diabetes Res Clin Pract (2008) 1.13
Quantitative studies with antilymphocytic antibody. Nature (1967) 1.13
Polymerase chain reaction screening for Y chromosome microdeletions: a first step towards the diagnosis of genetically-determined spermatogenic failure in men. Mol Hum Reprod (1996) 1.11
The antecedents of violence and aggression within psychiatric in-patient settings. Acta Psychiatr Scand (2012) 1.10
Studies on a unique diagnostic serum globulin in papular mucinosis (lichen myxedematosus). Clin Exp Immunol (1967) 1.10
Lipid peroxidation and prostaglandins in colorectal cancer. Br J Surg (1994) 1.09
The catalytic cycle of cytochrome P-450scc and intermediates in the conversion of cholesterol to pregnenolone. Eur J Biochem (1984) 1.08
Collagenase versus placebo in the treatment of Peyronie's disease: a double-blind study. J Urol (1993) 1.08
Presence of secretory leukocyte protease inhibitor in human endometrium and first trimester decidua suggests an antibacterial protective role. Mol Hum Reprod (2000) 1.08
Binding of C-reactive protein to human lymphocytes. II. Interaction with a subset of cells bearing the Fc receptor. J Immunol (1981) 1.08
Expression of natural antimicrobials by human placenta and fetal membranes. Placenta (2006) 1.07
The endocrinology of menstruation--a role for the immune system. Clin Endocrinol (Oxf) (2001) 1.07
Vasectomy by section, luminal fulguration and fascial interposition: results from 6248 cases. Br J Urol (1996) 1.07
Preliminary observations on the effect of heterologous anti-lymphocytic globulin on autologous immune complex nephritis in rats. Clin Exp Immunol (1969) 1.06
Gastric mucosal prostaglandin synthesis in the presence of Campylobacter pylori in patients with gastric ulcers and non-ulcer dyspepsia. Am J Gastroenterol (1990) 1.06
Mechanisms of action of intravesical bacille Calmette-Guérin: local immune mechanisms. Clin Infect Dis (2000) 1.06
Innate immune defences in the human uterus during pregnancy. Placenta (2007) 1.05
Distribution of fatty and fibrous plaques in young human coronary arteries. Atherosclerosis (1982) 1.05
Binding of C-reactive protein to human lymphocytes. I. Requirement for a binding specificity. J Immunol (1981) 1.05
Dose-response relationship for risk of non-vertebral fracture with inhaled corticosteroids. Clin Exp Allergy (2008) 1.05
Role for CD40-CD40 ligand interactions in the immune response to solid tumours. Mol Immunol (2000) 1.05
Dietary linoleic acid, gastric acid, and prostaglandin secretion. Gastroenterology (1988) 1.05
A membrane-covered photobacterium probe for oxygen measurements in the nanomolar range. Anal Biochem (1981) 1.04
Primary dysmenorrhoea: the importance of both prostaglandins E2 and F2 alpha. Br J Obstet Gynaecol (1983) 1.03
A role for prostacyclin (PGi2) in excessive menstrual bleeding. Lancet (1981) 1.03
Carcinoma in situ of the testis. Br Med J (Clin Res Ed) (1986) 1.03
The action of prostaglandin E2 on the human cervix: stimulation of interleukin 8 and inhibition of secretory leukocyte protease inhibitor. Am J Obstet Gynecol (1999) 1.03
Prediction of amputation wound healing with skin perfusion pressure. J Vasc Surg (1995) 1.02
Phase III comparative study of vinorelbine combined with doxorubicin versus doxorubicin alone in disseminated metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8. J Clin Oncol (2000) 1.02
Nesbit procedure for disabling Peyronie's curvature: a median follow-up of 84 months. Urology (2003) 1.02
Extracellular organelles (prostasomes) are immunosuppressive components of human semen. Clin Exp Immunol (1991) 1.02
Synovial cells. A study of the morphology and an examination of protein synthesis of synovial cells. Ann Rheum Dis (1966) 1.02
Association of alpha-macroglobulins with lymphoid cells. Nat New Biol (1973) 1.01
The effects of danazol, mefenamic acid, norethisterone and a progesterone-impregnated coil on endometrial prostaglandin concentrations in women with menorrhagia. Prostaglandins (1987) 1.00
Prostaglandin concentrations in the semen of fertile men. J Reprod Fertil (1978) 1.00
Effect of Corynebacterium parvum on the class and subclass of antibody produced in the response of different strains of mice to sheep erythrocytes. Immunology (1975) 1.00
In vitro studies on the heterogeneity of equine antibodies to human lymphoid tissue. Immunochemistry (1969) 1.00
The effect of anti-lymphocytic IgG on estab- lished autoallergic thyroiditis in rats. Clin Exp Immunol (1969) 0.99